Andrew Adams

Group Vice President - Molecule Discovery, Eli Lilly

Indianapolis, Indiana

About

Male

Andrew Adams is based out of Indianapolis, Indiana, and is the Group Vice President - Molecule Discovery of Eli Lilly and also the Chairman of the Board of Insilico Medicine. Andrew Adams attended the University of Aberdeen.

Experience

Eli Lilly

Group Vice President - Molecule Discovery · 2024 – present

View →

IPO15kBiotechnology · Health Care

Chairman of the Board · Insilico Medicine
2026 – present
Board Observer · BreezeBio
2021 – present
Board Member · DTx Pharma

Education

University of Aberdeen · B.Sc., Biology
– 2007
University of Aberdeen · PhD, Zoology, Neuroscience
2003

Headlines from Google News. Social posts load from the platform only when you open a tab.

Insilico launches industry's first Longevity Board with Lilly's Andrew Adams as chair, Nobel laureate Michael Levitt on roster
R&D World · Apr 21
Insilico Medicine Announces Industry’s First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery
insilico.com · Apr 21
US pharma giant reaches $2.75 billion deal with China-based biotech company for AI-developed drugs
thecooldown.com · Mar 31
Eli Lilly Is Diving Deeper Into AI Drug Discovery With Expanded Insilico Partnership
Yahoo Finance · Mar 30
Eli Lilly signs billion-dollar deal with AI specialist
medwatch.com · Mar 30

People at Eli Lilly

Sekar Kathiresan

Senior Vice President

Adam Fleisher

Medical Fellow, Clinical Lead

Data from: crunchbase